T M LaBounty1, W D Hardy2, Z Fan3, R Yumul4, D Li3, R Dharmakumar3,5, A Hernandez Conte4. 1. Departments of Medicine and Radiology, University of Michigan Medical Center, Ann Arbor, MI, USA. 2. David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA. 3. Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 4. Department of Anesthesiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 5. Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Abstract
OBJECTIVES: While patients with HIV infection have an elevated stroke risk, ultrasound studies of carotid artery wall thickness have reported variable results. We hypothesized that subjects with HIV infection on chronic highly active antiretroviral therapy (HAART) would have increased carotid artery wall thickness by magnetic resonance imaging (MRI). METHODS: This cross-sectional study compared carotid artery wall thickness between 26 individuals infected with HIV on chronic HAART and 20 controls, without HIV infection but with similar cardiovascular risk factors, using 3.0-T noncontrast MRI. Inclusion criteria included male gender, age 35-55 years, and chronic HAART (≥ 3 years) among HIV-seropositive subjects; those with known cardiovascular disease or diabetes were excluded. RESULTS: Between subjects with HIV infection and controls, there were no differences in mean (±SD) age (47.8 ± 5.0 vs. 47.8 ± 4.7 years, respectively; P = 0.19) or cardiovascular risk factors (P > 0.05 for each). Mean (±SD) wall thickness was increased in those with HIV infection vs. controls for the left (0.88 ± 0.08 vs. 0.83 ± 0.08 mm, respectively; P = 0.03) and right (0.90 ± 0.10 vs. 0.85 ± 0.07 mm, respectively; P = 0.046) common carotid arteries. Among individuals with HIV infection, variables associated with increased mean carotid artery wall thickness included lipoaccumulation [+0.09 mm; 95% confidence interval (CI) 0.03-0.14 mm; P = 0.003], Framingham risk score ≥ 5% (+0.07 mm; 95% CI 0.01-0.12; P = 0.02 mm), and increased duration of protease inhibitor therapy (+0.03 mm per 5 years; 95% CI 0.01-0.06 mm; P = 0.02). CONCLUSIONS: Individuals with HIV infection on chronic HAART had increased carotid artery wall thickness as compared to similar controls. In subjects with HIV infection, the presence of lipoaccumulation and longer duration of protease inhibitor therapy were associated with greater wall thickness.
OBJECTIVES: While patients with HIV infection have an elevated stroke risk, ultrasound studies of carotid artery wall thickness have reported variable results. We hypothesized that subjects with HIV infection on chronic highly active antiretroviral therapy (HAART) would have increased carotid artery wall thickness by magnetic resonance imaging (MRI). METHODS: This cross-sectional study compared carotid artery wall thickness between 26 individuals infected with HIV on chronic HAART and 20 controls, without HIV infection but with similar cardiovascular risk factors, using 3.0-T noncontrast MRI. Inclusion criteria included male gender, age 35-55 years, and chronic HAART (≥ 3 years) among HIV-seropositive subjects; those with known cardiovascular disease or diabetes were excluded. RESULTS: Between subjects with HIV infection and controls, there were no differences in mean (±SD) age (47.8 ± 5.0 vs. 47.8 ± 4.7 years, respectively; P = 0.19) or cardiovascular risk factors (P > 0.05 for each). Mean (±SD) wall thickness was increased in those with HIV infection vs. controls for the left (0.88 ± 0.08 vs. 0.83 ± 0.08 mm, respectively; P = 0.03) and right (0.90 ± 0.10 vs. 0.85 ± 0.07 mm, respectively; P = 0.046) common carotid arteries. Among individuals with HIV infection, variables associated with increased mean carotid artery wall thickness included lipoaccumulation [+0.09 mm; 95% confidence interval (CI) 0.03-0.14 mm; P = 0.003], Framingham risk score ≥ 5% (+0.07 mm; 95% CI 0.01-0.12; P = 0.02 mm), and increased duration of protease inhibitor therapy (+0.03 mm per 5 years; 95% CI 0.01-0.06 mm; P = 0.02). CONCLUSIONS: Individuals with HIV infection on chronic HAART had increased carotid artery wall thickness as compared to similar controls. In subjects with HIV infection, the presence of lipoaccumulation and longer duration of protease inhibitor therapy were associated with greater wall thickness.
Authors: M G Law; N Friis-Møller; W M El-Sadr; R Weber; P Reiss; A D'Arminio Monforte; R Thiébaut; L Morfeldt; S De Wit; C Pradier; G Calvo; O Kirk; C A Sabin; A N Phillips; J D Lundgren Journal: HIV Med Date: 2006-05 Impact factor: 3.180
Authors: M Bongiovanni; M Casana; P Cicconi; M Pisacreta; R Codemo; M Pelucchi; A d'Arminio Monforte; T Bini Journal: J Antimicrob Chemother Date: 2007-11-12 Impact factor: 5.790
Authors: Andreas Harloff; Timo Zech; Alex Frydrychowicz; Martin Schumacher; Joachim Schöllhorn; Jürgen Hennig; Cornelius Weiller; Michael Markl Journal: Eur Radiol Date: 2009-02-13 Impact factor: 5.315
Authors: Christine A Wanke; Julian M Falutz; Abby Shevitz; John P Phair; Donald P Kotler Journal: Clin Infect Dis Date: 2001-12-07 Impact factor: 9.079
Authors: Carl Grunfeld; Joseph A C Delaney; Christine Wanke; Judith S Currier; Rebecca Scherzer; Mary L Biggs; Phyllis C Tien; Michael G Shlipak; Stephen Sidney; Joseph F Polak; Daniel O'Leary; Peter Bacchetti; Richard A Kronmal Journal: AIDS Date: 2009-09-10 Impact factor: 4.177
Authors: Marit G A van Vonderen; Yvo M Smulders; Coen D A Stehouwer; Sven A Danner; Chad M Gundy; Frieda Vos; Peter Reiss; Michiel A van Agtmael Journal: J Acquir Immune Defic Syndr Date: 2009-02-01 Impact factor: 3.731
Authors: Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren Journal: N Engl J Med Date: 2007-04-26 Impact factor: 91.245
Authors: K M Farizo; J W Buehler; M E Chamberland; B M Whyte; E S Froelicher; S G Hopkins; C M Reed; E D Mokotoff; D L Cohn; S Troxler Journal: JAMA Date: 1992-04-01 Impact factor: 56.272
Authors: Laura A Benjamin; Alan Bryer; Hedley C A Emsley; Saye Khoo; Tom Solomon; Myles D Connor Journal: Lancet Neurol Date: 2012-10 Impact factor: 44.182
Authors: Dima A Hammoud; Sanhita Sinharay; Sally Steinbach; Paul G Wakim; Katrina Geannopoulos; Katherine Traino; Amit K Dey; Edmund Tramont; Stanley I Rapoport; Joseph Snow; Nehal N Mehta; Bryan R Smith; Avindra Nath Journal: Neurology Date: 2018-09-26 Impact factor: 9.910
Authors: Kyle D Murray; Meera V Singh; Yuchuan Zhuang; Md Nasir Uddin; Xing Qiu; Miriam T Weber; Madalina E Tivarus; Henry Z Wang; Bogachan Sahin; Jianhui Zhong; Sanjay B Maggirwar; Giovanni Schifitto Journal: Front Neurol Date: 2020-12-15 Impact factor: 4.003